Severe cutaneous drug reactions in children

被引:0
|
作者
Mockenhaupt, Maja [1 ,2 ]
机构
[1] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Freiburg, Germany
[2] Univ Klin Dermatol & Venerol, Dokumentat Zentrum Schwerer Hautreakt dZh, Hauptstr 7, D-79104 Freiburg, Germany
关键词
Epidermal necrolysis; Drug reaction with eosinophilia and systemic symptoms; Anticonvulsants; Sulfonamides; Sulfasalazine; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; SYSTEMIC SYMPTOMS; MULTIFORME MAJUS; DRESS; EPIDEMIOLOGY; SCORTEN;
D O I
10.1007/s00112-023-01753-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Severe cutaneous drug reactions also occur in children and range from reactions with blister forming of skin and mucosa to extensive exanthems with altered differential blood count and involvement of internal organs. The first group includes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are considered as one disease entity with different degrees of severity and are also referred to as "epidermal" or "epithelial necrolysis" (EN). The group of drug reactions with primarily systemic alterations is represented by a condition known as drug reaction with eosinophilia and systemic symptoms (DRESS). Although EN is generally considered as a drug reaction, a causative agent can only be identified in about 50% of all pediatric cases. Once a clear diagnosis is established, specific treatment measures should be carried out, whereby discontinuation of the causative agent plays a decisive role in drug-induced cases. In order to be able to identify and discontinue the drug responsible, a detailed medication history must be obtained. Certain antiepileptic drugs, sulfonamides and sulfasalazine are among the most frequent triggers of EN and DRESS in children. Supportive therapy including appropriate topical treatment, pain management and ophthalmological consultations are of utmost importance in EN but a short-term immunomodulating treatment with cyclosporine A has been shown to be helpful. In contrast, in DRESS middle to long-term systemic treatment with glucocorticosteroids is recommended.
引用
收藏
页码:439 / 451
页数:13
相关论文
共 50 条
  • [31] In vitro/ex vivo assays for severe cutaneous drug reactions
    Copaescu, Ana Maria
    Trubiano, Jason A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 152 (01) : 39 - 41
  • [32] severe cutaneous adverse drug reactions induced by allopurinol preventable?
    Ranchon, F.
    Debarbieux, S.
    Bensaid, B.
    Bernard, N.
    Nicolas, J. F.
    Descotes, J.
    Vial, T.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 103 - 103
  • [33] Clinical Features and Prognostic Factors in Severe Cutaneous Drug Reactions
    Yang, Min-Suk
    Kang, Min-Gyu
    Jung, Jae-Woo
    Song, Woo-Jung
    Kang, Hye-Ryun
    Cho, Sang-Heon
    Min, Kyung-Up
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2013, 162 (04) : 346 - 354
  • [34] Identifying genetic predictors of severe cutaneous adverse drug reactions
    Boothman, Isabelle
    McCormack, Mark
    Amstutz, Ursula
    Shear, Neil
    Gamberdella, Antonio
    Sills, Graeme
    Rener-Premec, Zvonka
    Lerche, Holger
    Kunz, Wolfram
    Depondt, Chantal
    Zara, Federico
    Striano, Pasquale
    Delanty, Norman
    Ingason, Andres
    Diehl, Sarah
    Krause, Roland
    Sisodiya, Sanjay
    Ross, Colin
    Carleton, Bruce
    Cavalleri, Gianpiero
    Wright, Galen
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 2) : 65 - 66
  • [35] Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
    Horcajada-Reales, C.
    Pulido-Perez, A.
    Suarez-Fernandez, R.
    ACTAS DERMO-SIFILIOGRAFICAS, 2016, 107 (01): : 23 - 33
  • [36] Identifying the Culprit Drug in Severe Cutaneous Adverse Reactions (SCARs)
    Cabanas, Rosario
    Ramirez, Elena
    Bellon, Teresa
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2021, 8 (03) : 194 - 209
  • [37] Genetic Markers for Severe Cutaneous Adverse Drug Reactions of Phenytoin
    Tassaneeyakul, W.
    Tiamkao, S.
    Prabmeechai, N.
    Konyoung, P.
    Chumworathayi, P.
    Sukasem, C.
    Kongpan, T.
    Saksit, N.
    Sangviroon, A.
    Vannaprasath, S.
    Kanjanawat, S.
    Wichukchinda, N.
    Mahasirimongkol, S.
    Inunchot, W.
    Chaiyakunapruk, N.
    Tassaneeyakul, W.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 5 - 5
  • [38] Severe cutaneous drug reactions to misused griseofulvin: 2 cases
    Le Guern, A.
    Kerrad, I.
    Oehler, E.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2016, 143 (03): : 219 - 222
  • [39] SEVERE CUTANEOUS DRUG-REACTIONS - CASE-REPORTS
    HEROLD, M
    OLTMANNS, G
    DUCK, HJ
    MARU, M
    ETHIOPIAN MEDICAL JOURNAL, 1983, 21 (04) : 227 - 232
  • [40] Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions
    Gibson, Andrew
    Deshpande, Pooja
    Campbell, Chelsea N.
    Krantz, Matthew S.
    Mukherjee, Eric
    Mockenhaupt, Maja
    Pirmohamed, Munir
    Palubinsky, Amy M.
    Phillips, Elizabeth J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : 289 - +